Stock detail
Replimune (REPL) stock price, chart, and key data
View Replimune stock price, chart movement, and headline metrics on Woodstock's stock detail page.
Stock detail
Replimune
REPL · XNAS
+$2.04 (+71.08%) past month
$4.91
After hours $4.95 (+0.89%)
Key metrics
Close price
$4.91
52-week range
$1.50 - $13.24
Market cap
$431M
About the company
Replimune Group Inc
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3. The company operates in USA and UK, majority of revenue from USA.
24/5 Trading
Act on the stock when the timing works for you.
With Woodstock, you can move from chart review to order placement in one flow. Trade eligible US stocks 24/5, even outside regular market hours.
*24-hour trading is available except during system maintenance. Some stocks are not eligible for extended-hours trading.
Download the app